Doctor profile · Federal record
Dr. SALLY BODENSTEINER, M.D.
Family Medicine Physician (CMS: FAMILY PRACTICE) · General Practice Physician · VINCENNES, IN
- NPI 1851580823
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
406 N 1ST ST
VINCENNES, IN 475911340
(812) 882-1106
fax (812) 885-2758
Credentials & registration
- NPI registered
- October 2007 — 19 yrs on file
- Profile last updated
- May 21, 2015
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State licenses (2)
- Indiana #01074304A · New Mexico #MD2008-0602
- Medicaid
- IN #201260890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851580823. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
151
Distinct HCPCS
4
Medicare allowed
$4,858
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
83036 |
Hemoglobin a1c level | 90 | 48 | $9 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 29 | 24 | $121 | |
81003 |
Automated urinalysis test | 18 | 14 | $2 | |
87426 |
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | 13 | $35 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 143. This provider delivers 1.1× the peer median.Open Payments
Industry payments received
All-time total
$448
Transactions
26
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $65.23 | |
| Vanda Pharmaceuticals Inc. | 2 | $42.29 | |
| Novo Nordisk Inc | 3 | $42.14 | |
| Indivior Inc. | 2 | $38.65 | |
| Amgen Inc. | 2 | $36.33 | |
| ABBVIE INC. | 2 | $30.80 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28.62 | |
| Lilly USA, LLC | 2 | $28.36 | |
| Hologic Sales and Service, LLC | 1 | $27.40 | |
| AIMMUNE THERAPEUTICS, INC. | 1 | $20.09 | |
| PFIZER INC. | 1 | $17.41 | |
| Alkermes, Inc. | 1 | $16.30 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14.21 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $13.57 | |
| AstraZeneca Pharmaceuticals LP | 1 | $13.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,462
Patients
744
Total drug cost
$49,899
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 874 | 170 | $12,327 |
| Lisinopril | Generic | 341 | 75 | $3,002 |
| Levothyroxine Sodium | Generic | 264 | 55 | $4,517 |
| Omeprazole | Generic | 226 | 54 | $2,778 |
| Montelukast Sodium | Generic | 223 | 38 | $4,123 |
| Gabapentin | Generic | 200 | 35 | $2,353 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 188 | 43 | $2,020 |
| Furosemide | Generic | 184 | 45 | $1,160 |
| Metoprolol Succinate | Generic | 174 | 37 | $2,910 |
| Amlodipine Besylate | Generic | 165 | 39 | $1,088 |